MD20150017A2 - Utilizarea preparatului Polibiolin la pacienţii cu ciroză hepatică - Google Patents

Utilizarea preparatului Polibiolin la pacienţii cu ciroză hepatică

Info

Publication number
MD20150017A2
MD20150017A2 MDA20150017A MD20150017A MD20150017A2 MD 20150017 A2 MD20150017 A2 MD 20150017A2 MD A20150017 A MDA20150017 A MD A20150017A MD 20150017 A MD20150017 A MD 20150017A MD 20150017 A2 MD20150017 A2 MD 20150017A2
Authority
MD
Moldova
Prior art keywords
drug
polybiolin
patients
liver cirrhosis
medicine
Prior art date
Application number
MDA20150017A
Other languages
English (en)
Russian (ru)
Other versions
MD4458B1 (ro
MD4458C1 (ro
Inventor
Maria Danu
Galina Pavliuc
Original Assignee
Maria Danu
Galina Pavliuc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maria Danu, Galina Pavliuc filed Critical Maria Danu
Priority to MDA20150017A priority Critical patent/MD4458C1/ro
Publication of MD20150017A2 publication Critical patent/MD20150017A2/ro
Publication of MD4458B1 publication Critical patent/MD4458B1/ro
Publication of MD4458C1 publication Critical patent/MD4458C1/ro

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Invenţia se referă la medicină, şi anume la utilizarea preparatului Polibiolin la pacienţii cu ciroză hepatică, totodată preparatul se administrează intramuscular, cate 5 ml în decurs de 8…10 zile.
MDA20150017A 2014-06-19 2014-06-19 Utilizarea preparatului Polibiolină în tratamentul bolnavilor cu ciroză hepatică MD4458C1 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20150017A MD4458C1 (ro) 2014-06-19 2014-06-19 Utilizarea preparatului Polibiolină în tratamentul bolnavilor cu ciroză hepatică

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20150017A MD4458C1 (ro) 2014-06-19 2014-06-19 Utilizarea preparatului Polibiolină în tratamentul bolnavilor cu ciroză hepatică

Publications (3)

Publication Number Publication Date
MD20150017A2 true MD20150017A2 (ro) 2016-04-30
MD4458B1 MD4458B1 (ro) 2017-01-31
MD4458C1 MD4458C1 (ro) 2017-08-31

Family

ID=55911138

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20150017A MD4458C1 (ro) 2014-06-19 2014-06-19 Utilizarea preparatului Polibiolină în tratamentul bolnavilor cu ciroză hepatică

Country Status (1)

Country Link
MD (1) MD4458C1 (ro)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0827742A1 (en) * 1996-09-04 1998-03-11 Vrije Universiteit Brussel Use of histone deacetylase inhibitors for treating fribosis or cirrhosis
MD1780G2 (ro) * 2001-02-02 2002-05-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de tratament al pacienţilor cu ciroze hepatice
DE102005025906A1 (de) * 2005-06-06 2006-12-07 Dorian Bevec Therapeutischer Gebrauch aromatischer Guanylhydrazone zur Behandlung von Hepatitis C Virus-verursachten Erkrankungen
DE102005059750A1 (de) * 2005-12-09 2007-06-14 Salama, Zoser Boulis, Dr. Antikrebsmittel umfassend Arsen-Verbindungen
FR2952826B1 (fr) * 2009-11-20 2012-04-06 Lab Francais Du Fractionnement Utilisation d'immunoglobulines polyvalentes pour traiter une cirrhose hepatique alcoolique ou metabolique
MD4317C1 (ro) * 2013-09-12 2015-08-31 Георге АНГЕЛИЧ Utilizarea propionatului de 3-(2, 2, 2-trimetilhidraziniu) dihidrat pentru tratamentul pacienţilor cu ciroză hepatică avansată asociată cu insuficienţă cardiacă

Also Published As

Publication number Publication date
MD4458B1 (ro) 2017-01-31
MD4458C1 (ro) 2017-08-31

Similar Documents

Publication Publication Date Title
PH12016501830A1 (en) Inhibitors of c5a for the treatment of viral pneumonia
TN2017000554A1 (en) Novel combination for use in the treatment of cancer
MX370792B (es) Composiciones para usarse en el tratamiento de cáncer.
PH12016502352A1 (en) Pharmaceutical composition
TW201613578A (en) Pharmaceutical combinations
EA201790726A1 (ru) Фармацевтическая композиция для лечения язвенного колита
EA201691918A1 (ru) Фармацевтические составы ингибитора киназ семейства raf, способы их получения и способы их применения
NZ710291A (en) 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
MX2018006226A (es) Agente estimulador del receptor 1b de 5-hidroxitriptamina para mejorar el potencial de injerto in vivo.
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
MD4763B1 (ro) Compoziţie farmaceutică
PH12017500323A1 (en) P38 map kinase inhibiting indanyl urea compounds
MD20150017A2 (ro) Utilizarea preparatului Polibiolin la pacienţii cu ciroză hepatică
MX2016013979A (es) Nuevas vias de administracion de insulina, analogos de insulina o derivados de insulina.
MD4317C1 (ro) Utilizarea propionatului de 3-(2, 2, 2-trimetilhidraziniu) dihidrat pentru tratamentul pacienţilor cu ciroză hepatică avansată asociată cu insuficienţă cardiacă
TR201716203A1 (tr) Yeni umeklidinyum formülasyonları.
MX2017005669A (es) Derivados de hidroxido de bencilo, preparacion de los mismos y uso terapeutico de los mismos.
MD4316B1 (en) Use of 3-(2,2,2-trimethylhydrazinium)propionate dihydrate for treating portal gastropathies in patients with liver cirrhosis
PL414785A1 (pl) Kwas 3-dodecylosulfanylomasłowy do zastosowania jako lek, zwłaszcza do zapobiegania rozwojowi insulinooporności oraz kompozycja farmaceutyczna zawierająca kwas 3-dodecylosulfanylomasłowy jako substancję czynną
BR112017003900A2 (pt) formulações de testosterona e métodos de tratamento com as mesmas
IN2014DE00822A (ro)
IN2013MU03838A (ro)
MX366763B (es) Composiciones farmacéuticas de montelukast y levocetirizina.
UA91605U (uk) Спосіб корекції порушень мікроциркуляції в слизовій оболонці шлунка у людей літнього віку

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees